Literature DB >> 28212760

Psoriasis and comorbid diseases: Implications for management.

Junko Takeshita1, Sungat Grewal2, Sinéad M Langan3, Nehal N Mehta4, Alexis Ogdie5, Abby S Van Voorhees6, Joel M Gelfand7.   

Abstract

As summarized in the first article in this continuing medical education series, the currently available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic disease. Emerging data also suggest associations between psoriasis and other comorbidities beyond psoriatic arthritis, including chronic kidney disease, inflammatory bowel disease, hepatic disease, certain malignancies, infections, and mood disorders. Recognizing the comorbid disease burden of psoriasis is essential for ensuring comprehensive care of patients with psoriasis. The clinical implications of the comorbid diseases that are associated with psoriasis and recommendations for clinical management are reviewed in this article.
Copyright © 2016 American Academy of Dermatology, Inc. All rights reserved.

Entities:  

Keywords:  Crohn's disease; cardiovascular disease; chronic kidney disease; comorbidities; depression; infection; lymphoma; metabolic syndrome; nonalcoholic fatty liver disease; psoriasis; psoriatic arthritis; screening; vaccination

Mesh:

Substances:

Year:  2017        PMID: 28212760      PMCID: PMC5839668          DOI: 10.1016/j.jaad.2016.07.065

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  92 in total

1.  Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists.

Authors:  Kory K Parsi; Elizabeth A Brezinski; Tzu-Chun Lin; Chin-Shang Li; April W Armstrong
Journal:  J Am Acad Dermatol       Date:  2011-11-12       Impact factor: 11.527

2.  Psoriasis and cardiovascular disease: an association or a reason to treat?

Authors:  D J Margolis
Journal:  Br J Dermatol       Date:  2011-11       Impact factor: 9.302

3.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

4.  Risk of depression in women with psoriasis: a cohort study.

Authors:  E D Dommasch; T Li; O I Okereke; Y Li; A A Qureshi; E Cho
Journal:  Br J Dermatol       Date:  2015-09-24       Impact factor: 9.302

5.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

6.  The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study.

Authors:  K Abuabara; H Lee; A B Kimball
Journal:  Br J Dermatol       Date:  2011-11       Impact factor: 9.302

Review 7.  Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Radjiv Goulabchand; Gaël Mouterde; Thomas Barnetche; Cédric Lukas; Jacques Morel; Bernard Combe
Journal:  Ann Rheum Dis       Date:  2013-01-25       Impact factor: 19.103

8.  Psoriasis severity and the prevalence of major medical comorbidity: a population-based study.

Authors:  Howa Yeung; Junko Takeshita; Nehal N Mehta; Stephen E Kimmel; Alexis Ogdie; David J Margolis; Daniel B Shin; Rosemary Attor; Andrea B Troxel; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2013-10       Impact factor: 10.282

9.  Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.

Authors:  R M R Hearn; A C Kerr; K F Rahim; J Ferguson; R S Dawe
Journal:  Br J Dermatol       Date:  2008-09       Impact factor: 9.302

10.  Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis.

Authors:  Kaisa M Mäki-Petäjä; Maysoon Elkhawad; Joseph Cheriyan; Francis R Joshi; Andrew J K Ostör; Frances C Hall; James H F Rudd; Ian B Wilkinson
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

View more
  38 in total

1.  Exploring genetic targets of psoriasis using genome wide association studies (GWAS) for drug repurposing.

Authors:  Harshit Nanda; Nirmaladevi Ponnusamy; Rajasree Odumpatta; Jeyaraman Jeyakanthan; Arumugam Mohanapriya
Journal:  3 Biotech       Date:  2020-01-10       Impact factor: 2.406

2.  Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish Study.

Authors:  Kirk Geale; Martin Henriksson; Jussi Jokinen; Marcus Schmitt-Egenolf
Journal:  JAMA Dermatol       Date:  2020-07-01       Impact factor: 10.282

Review 3.  IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.

Authors:  Hao Li; George C Tsokos
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-13       Impact factor: 8.667

Review 4.  Psoriasis pathogenesis and the development of novel targeted immune therapies.

Authors:  Jason E Hawkes; Tom C Chan; James G Krueger
Journal:  J Allergy Clin Immunol       Date:  2017-09       Impact factor: 10.793

Review 5.  Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis.

Authors:  Jason E Hawkes; Bernice Y Yan; Tom C Chan; James G Krueger
Journal:  J Immunol       Date:  2018-09-15       Impact factor: 5.422

Review 6.  IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.

Authors:  J M Fletcher; B Moran; A Petrasca; C M Smith
Journal:  Clin Exp Immunol       Date:  2020-06-08       Impact factor: 4.330

7.  Integrated metabolomic analysis and cytokine profiling define clusters of immuno-metabolic correlation in new-onset psoriasis.

Authors:  Elisabetta Tarentini; Giulia Odorici; Valeria Righi; Alessia Paganelli; Luca Giacomelli; Valentina Mirisola; Adele Mucci; Luisa Benassi; Elisabetta D'Aversa; Claudia Lasagni; Shaniko Kaleci; Eva Reali; Cristina Magnoni
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

8.  Association of Metabolic Comorbidities with Pediatric Psoriasis: A Systematic Review and Meta-Analysis.

Authors:  Soo Ick Cho; Ye Eun Kim; Seong Jin Jo
Journal:  Ann Dermatol       Date:  2021-05-04       Impact factor: 1.444

9.  Association of Benzodiazepine Receptor Agonist Use With Changes in Psoriasis Severity in Adult Population: A Population-Based Study.

Authors:  Ke-Ting Pan; I-Hsun Li; Hui-Han Kao; Yi-Hsien Chen; Pei-Xun Zhong; Li-Ting Kao
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

Review 10.  Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk.

Authors:  C Elise Kleyn; Peter S Talbot; Nehal N Mehta; Francesca Sampogna; Chris Bundy; Darren M Ashcroft; Alexa B Kimball; Peter C M van de Kerkhof; Christopher E M Griffiths; Fernando Valenzuela; Joelle M van der Walt; Tsion Aberra; Lluís Puig
Journal:  Acta Derm Venereol       Date:  2020-01-07       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.